IBSA Pharma SRL
2.0 FTEThe score of IBSA Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +27 % Total assets -18 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
IBSA Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 May 2026
- Year ended 31 Dec 2024filed on 08 May 2025
- Year ended 31 Dec 2023filed on 29 Jul 2024
IBSA Pharma's financial analysis
- Solvency48.6%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of IBSA Pharma
IBSA Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0795.266.574
- VAT number
- BE0795266574
- Peppol
- Registered · 0208:0795266574 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Dec 2022
- Registered office
- 1000 Brussels
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 19 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
IBSA Pharma (SRL) has been based in Brussels since 2022, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 1,299 € and equity of 34,853 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 48.6%, above the median of its sector (32.3%).
Companies similar to IBSA Pharma
Companies in the same business, of comparable size and area, outside its group.
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Enzo Life Sciences Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 142,693 €
- Accuray Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet 257,954 €
- Medicatronics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet 236,934 €
- AlphaCare Wholesale of pharmaceutical and medical goods Grez-Doiceau · balance sheet 559,557 €
- Belderm Wholesale of pharmaceutical and medical goods Woluwe-Saint-Lambert · balance sheet 7,299 €
- Corcym Belgium Wholesale of pharmaceutical and medical goods Saint-Josse-ten-Noode · balance sheet €1.30m
- Esteve Pharmaceuticals Wholesale of pharmaceutical and medical goods Jette · balance sheet €2.91m
Frequently asked questions about IBSA Pharma
What is the revenue of IBSA Pharma?
IBSA Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of IBSA Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0795266574 for IBSA Pharma, if the company is VAT-registered. Its company number (CBE) is 0795.266.574.
Where is the registered office of IBSA Pharma?
According to the CBE register, the registered office of IBSA Pharma is in 1000 Brussels.
What is the equity of IBSA Pharma?
At the close of the 2025 financial year, the equity of IBSA Pharma amounts to 34,853 €, a solvency of 48.6% of total assets.
How many people work at IBSA Pharma?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages IBSA Pharma?
The register lists 4 active mandates at IBSA Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of IBSA Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →